Dilini Gunatilake

765 total citations
12 papers, 624 citations indexed

About

Dilini Gunatilake is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dilini Gunatilake has authored 12 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Dilini Gunatilake's work include Histone Deacetylase Inhibitors Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Ubiquitin and proteasome pathways (4 papers). Dilini Gunatilake is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Ubiquitin and proteasome pathways (4 papers). Dilini Gunatilake collaborates with scholars based in Australia, United States and United Kingdom. Dilini Gunatilake's co-authors include Stuart Gallagher, Jessamy Tiffen, Peter Hersey, Kavitha Gowrishankar, Helen Rizos, Carleen Cullinane, Grant A. McArthur, Gulietta M. Pupo, Jason Madore and Anja Heinemann and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

In The Last Decade

Dilini Gunatilake

12 papers receiving 619 citations

Peers

Countries citing papers authored by Dilini Gunatilake

Since Specialization

Citations

This map shows the geographic impact of Dilini Gunatilake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilini Gunatilake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilini Gunatilake more than expected).

Fields of papers citing papers by Dilini Gunatilake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilini Gunatilake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilini Gunatilake. The network helps show where Dilini Gunatilake may publish in the future.

Co-authorship network of co-authors of Dilini Gunatilake

This figure shows the co-authorship network connecting the top 25 collaborators of Dilini Gunatilake. A scholar is included among the top collaborators of Dilini Gunatilake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilini Gunatilake. Dilini Gunatilake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Vascular senescence and leak are features of the early breakdown of the blood–brain barrier in Alzheimer’s disease models 2023 ·GeroScience ·Ka Ka Ting, Paul Coleman, Hani Jieun Kim, Yang Zhao, (unknown), Ngan Ching Cheng, Wan Li, Dilini Gunatilake, Daniel M. Johnstone, Lipin Loo, G. Gregory Neely, Pengyi Yang, Jürgen Götz, Mathew A. Vadas, Jennifer R. Gamble	42
2	A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma 2021 ·Journal of Investigative Dermatology ·Abdullah Al Emran, Hsin‐Yi Tseng, Dilini Gunatilake, (unknown), Farzana Ahmed, Shudong Wang, Peter Hersey, Stuart Gallagher, Jessamy Tiffen	10
3	Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma 2021 ·Journal of Investigative Dermatology ·Farzana Ahmed, Hsin‐Yi Tseng, Antonio Ahn, Dilini Gunatilake, Sara Alavi, Michael R. Eccles, Helen Rizos, Stuart Gallagher, Jessamy Tiffen, Peter Hersey, Abdullah Al Emran	16
4	EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma 2020 ·Journal of Investigative Dermatology ·Jessamy Tiffen, Stuart Gallagher, Fabian V. Filipp, Dilini Gunatilake, Abdullah Al Emran, Carleen Cullinane, Ken Dutton‐Regester, Lauren G. Aoude, Nicholas K. Hayward, Aniruddha Chatterjee, Euan J. Rodger, Michael R. Eccles, Peter Hersey	49
5	Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma 2020 ·International Journal of Cancer ·Hsin‐Yi Tseng, (unknown), Abdullah Al Emran, Dilini Gunatilake, (unknown), Carleen Cullinane, Ken Dutton‐Regester, Helen Rizos, Nicholas K. Hayward, Grant A. McArthur, Peter Hersey, Jessamy Tiffen, Stuart Gallagher	20
6	HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma 2017 ·International Journal of Cancer ·Stuart Gallagher, Dilini Gunatilake, Kimberley A. Beaumont, Danae M. Sharp, Jessamy Tiffen, Anja Heinemann, Wolfgang Weninger, Nikolas K. Haass, James S. Wilmott, Jason Madore, Peter M. Ferguson, Helen Rizos, Peter Hersey	41
7	Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB 2015 ·PLoS ONE ·Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher, Jessamy Tiffen, Helen Rizos, Peter Hersey	191
8	Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling 2015 ·Oncotarget ·Anja Heinemann, Carleen Cullinane, Ricardo De Paoli‐Iseppi, James S. Wilmott, Dilini Gunatilake, Jason Madore, Dario Strbenac, Jean Yang, Kavitha Gowrishankar, Jessamy Tiffen, Rab K. Prinjha, Nicholas Smithers, Grant A. McArthur, Peter Hersey, Stuart Gallagher	71
9	Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes 2015 ·Oncotarget ·Jessamy Tiffen, Dilini Gunatilake, Stuart Gallagher, Kavitha Gowrishankar, Anja Heinemann, Carleen Cullinane, Ken Dutton‐Regester, Gulietta M. Pupo, Dario Strbenac, Jean Yang, Jason Madore, Graham J. Mann, Nicholas K. Hayward, Grant A. McArthur, Fabian V. Filipp, Peter Hersey	62
10	The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells 2014 ·Journal of Investigative Dermatology ·Stuart Gallagher, Branka Mijatov, Dilini Gunatilake, Jessamy Tiffen, Kavitha Gowrishankar, Lei Jin, Gulietta M. Pupo, Carleen Cullinane, Rab K. Prinjha, Nicholas Smithers, Grant A. McArthur, Helen Rizos, Peter Hersey	51
11	Abstract 2947: Regulation of PD-L1 expression in human melanoma by NF-kB 2014 ·Cancer Research ·Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher, Jessamy Tiffen, Peter Hersey	1
12	Control of NF‐kB activity in human melanoma by bromodomain and extra‐terminal protein inhibitor I‐BET151 2014 ·Pigment Cell & Melanoma Research ·Stuart Gallagher, Branka Mijatov, Dilini Gunatilake, Kavitha Gowrishankar, Jessamy Tiffen, (unknown), Lei Jin, Gulietta M. Pupo, Carleen Cullinane, Grant A. McArthur, Peter J. Tummino, Helen Rizos, Peter Hersey	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact